Dominant Strategy : Sell
Time series to forecast n: 21 Jun 2023 for 4 Weeks
Methodology : Modular Neural Network (Market Direction Analysis)
Summary
Provention Bio Inc. Common Stock prediction model is evaluated with Modular Neural Network (Market Direction Analysis) and Pearson Correlation1,2,3,4 and it is concluded that the PRVB stock is predictable in the short/long term. Modular neural networks (MNNs) are a type of artificial neural network that can be used for market direction analysis. MNNs are made up of multiple smaller neural networks, called modules. Each module is responsible for learning a specific task, such as identifying patterns in data or predicting future price movements. The modules are then combined to form a single neural network that can perform multiple tasks.In the context of market direction analysis, MNNs can be used to identify patterns in market data that suggest that the market is likely to move in a particular direction. This information can then be used to make predictions about future price movements. According to price forecasts for 4 Weeks period, the dominant strategy among neural network is: Sell
Key Points
- Why do we need predictive models?
- Understanding Buy, Sell, and Hold Ratings
- Nash Equilibria
PRVB Target Price Prediction Modeling Methodology
We consider Provention Bio Inc. Common Stock Decision Process with Modular Neural Network (Market Direction Analysis) where A is the set of discrete actions of PRVB stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation.1,2,3,4
F(Pearson Correlation)5,6,7= X R(Modular Neural Network (Market Direction Analysis)) X S(n):→ 4 Weeks
n:Time series to forecast
p:Price signals of PRVB stock
j:Nash equilibria (Neural Network)
k:Dominated move
a:Best response for target price
Modular Neural Network (Market Direction Analysis)
Modular neural networks (MNNs) are a type of artificial neural network that can be used for market direction analysis. MNNs are made up of multiple smaller neural networks, called modules. Each module is responsible for learning a specific task, such as identifying patterns in data or predicting future price movements. The modules are then combined to form a single neural network that can perform multiple tasks.In the context of market direction analysis, MNNs can be used to identify patterns in market data that suggest that the market is likely to move in a particular direction. This information can then be used to make predictions about future price movements.Pearson Correlation
Pearson correlation, also known as Pearson's product-moment correlation, is a measure of the linear relationship between two variables. It is a statistical measure that assesses the strength and direction of a linear relationship between two variables. The sign of the correlation coefficient indicates the direction of the relationship, while the magnitude of the correlation coefficient indicates the strength of the relationship. A correlation coefficient of 0.9 indicates a strong positive correlation, while a correlation coefficient of 0.2 indicates a weak positive correlation.
For further technical information as per how our model work we invite you to visit the article below:
How do AC Investment Research machine learning (predictive) algorithms actually work?
PRVB Stock Forecast (Buy or Sell) for 4 Weeks
Sample Set: Neural NetworkStock/Index: PRVB Provention Bio Inc. Common Stock
Time series to forecast n: 21 Jun 2023 for 4 Weeks
According to price forecasts for 4 Weeks period, the dominant strategy among neural network is: Sell
X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)
Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)
Z axis (Grey to Black): *Technical Analysis%
IFRS Reconciliation Adjustments for Provention Bio Inc. Common Stock
- An entity shall apply this Standard for annual periods beginning on or after 1 January 2018. Earlier application is permitted. If an entity elects to apply this Standard early, it must disclose that fact and apply all of the requirements in this Standard at the same time (but see also paragraphs 7.1.2, 7.2.21 and 7.3.2). It shall also, at the same time, apply the amendments in Appendix C.
- If a collar, in the form of a purchased call and written put, prevents a transferred asset from being derecognised and the entity measures the asset at fair value, it continues to measure the asset at fair value. The associated liability is measured at (i) the sum of the call exercise price and fair value of the put option less the time value of the call option, if the call option is in or at the money, or (ii) the sum of the fair value of the asset and the fair value of the put option less the time value of the call option if the call option is out of the money. The adjustment to the associated liability ensures that the net carrying amount of the asset and the associated liability is the fair value of the options held and written by the entity. For example, assume an entity transfers a financial asset that is measured at fair value while simultaneously purchasing a call with an exercise price of CU120 and writing a put with an exercise price of CU80. Assume also that the fair value of the asset is CU100 at the date of the transfer. The time value of the put and call are CU1 and CU5 respectively. In this case, the entity recognises an asset of CU100 (the fair value of the asset) and a liability of CU96 [(CU100 + CU1) – CU5]. This gives a net asset value of CU4, which is the fair value of the options held and written by the entity.
- For some types of fair value hedges, the objective of the hedge is not primarily to offset the fair value change of the hedged item but instead to transform the cash flows of the hedged item. For example, an entity hedges the fair value interest rate risk of a fixed-rate debt instrument using an interest rate swap. The entity's hedge objective is to transform the fixed-interest cash flows into floating interest cash flows. This objective is reflected in the accounting for the hedging relationship by accruing the net interest accrual on the interest rate swap in profit or loss. In the case of a hedge of a net position (for example, a net position of a fixed-rate asset and a fixed-rate liability), this net interest accrual must be presented in a separate line item in the statement of profit or loss and other comprehensive income. This is to avoid the grossing up of a single instrument's net gains or losses into offsetting gross amounts and recognising them in different line items (for example, this avoids grossing up a net interest receipt on a single interest rate swap into gross interest revenue and gross interest expense).
- For example, when the critical terms (such as the nominal amount, maturity and underlying) of the hedging instrument and the hedged item match or are closely aligned, it might be possible for an entity to conclude on the basis of a qualitative assessment of those critical terms that the hedging instrument and the hedged item have values that will generally move in the opposite direction because of the same risk and hence that an economic relationship exists between the hedged item and the hedging instrument (see paragraphs B6.4.4–B6.4.6).
*International Financial Reporting Standards (IFRS) adjustment process involves reviewing the company's financial statements and identifying any differences between the company's current accounting practices and the requirements of the IFRS. If there are any such differences, neural network makes adjustments to financial statements to bring them into compliance with the IFRS.
Conclusions
Provention Bio Inc. Common Stock is assigned short-term B2 & long-term Ba3 estimated rating. Provention Bio Inc. Common Stock prediction model is evaluated with Modular Neural Network (Market Direction Analysis) and Pearson Correlation1,2,3,4 and it is concluded that the PRVB stock is predictable in the short/long term. According to price forecasts for 4 Weeks period, the dominant strategy among neural network is: Sell
PRVB Provention Bio Inc. Common Stock Financial Analysis*
Rating | Short-Term | Long-Term Senior |
---|---|---|
Outlook* | B2 | Ba3 |
Income Statement | C | B1 |
Balance Sheet | Ba3 | C |
Leverage Ratios | Caa2 | Baa2 |
Cash Flow | B2 | Baa2 |
Rates of Return and Profitability | Ba3 | Caa2 |
*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?
Prediction Confidence Score
References
- Athey S, Tibshirani J, Wager S. 2016b. Generalized random forests. arXiv:1610.01271 [stat.ME]
- Lai TL, Robbins H. 1985. Asymptotically efficient adaptive allocation rules. Adv. Appl. Math. 6:4–22
- Zubizarreta JR. 2015. Stable weights that balance covariates for estimation with incomplete outcome data. J. Am. Stat. Assoc. 110:910–22
- Matzkin RL. 1994. Restrictions of economic theory in nonparametric methods. In Handbook of Econometrics, Vol. 4, ed. R Engle, D McFadden, pp. 2523–58. Amsterdam: Elsevier
- Van der Vaart AW. 2000. Asymptotic Statistics. Cambridge, UK: Cambridge Univ. Press
- Allen, P. G. (1994), "Economic forecasting in agriculture," International Journal of Forecasting, 10, 81–135.
- D. White. Mean, variance, and probabilistic criteria in finite Markov decision processes: A review. Journal of Optimization Theory and Applications, 56(1):1–29, 1988.
Frequently Asked Questions
Q: What is the prediction methodology for PRVB stock?A: PRVB stock prediction methodology: We evaluate the prediction models Modular Neural Network (Market Direction Analysis) and Pearson Correlation
Q: Is PRVB stock a buy or sell?
A: The dominant strategy among neural network is to Sell PRVB Stock.
Q: Is Provention Bio Inc. Common Stock stock a good investment?
A: The consensus rating for Provention Bio Inc. Common Stock is Sell and is assigned short-term B2 & long-term Ba3 estimated rating.
Q: What is the consensus rating of PRVB stock?
A: The consensus rating for PRVB is Sell.
Q: What is the prediction period for PRVB stock?
A: The prediction period for PRVB is 4 Weeks
People also ask
⚐ What are the top stocks to invest in right now?☵ What happens to stocks when they're delisted?